Patents by Inventor Eric Andre
Eric Andre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240109889Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: ApplicationFiled: September 19, 2023Publication date: April 4, 2024Applicant: C4 Therapeutics, Inc.Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
-
Publication number: 20240105967Abstract: The invention relates to a bipolar plate for a fuel cell stack that extends in a vertical plane in the use position, the plate comprising opposed first and second transverse edges, upper and lower longitudinal edges, a central region arranged between the edges, a first opening for a heat transfer fluid inlet, a second opening for heat transfer fluid collection a third opening for an oxidant inlet, a fourth opening for oxidant collection, a fifth opening for the inlet of a fuel, a sixth opening for fuel collection, wherein the first, third and sixth openings are arranged in the first transverse edge and are arranged axially in relation to one another, the second, fourth and fifth openings are arranged in the second transverse edge and are arranged axially in relation to one another, and, in the vertical position of use of the plate: the sixth opening are arranged below the first and third openings, the fourth opening is arranged below the second and fifth openings, and the second opening is arranged above theType: ApplicationFiled: November 17, 2023Publication date: March 28, 2024Applicant: L'Air Liquide, Societe Anonyme pour l'Etude et l’Exploitation des Procedes Georges ClaudeInventors: Johan ANDRE, Camille BOUVIER, Eric CLAUDE, Nicolas JANNIN, Denis SIRAC, Didier ZAEPFFEL
-
Patent number: 11938584Abstract: A chemical mechanical polishing pad includes a surface portion of a first material. The surface portion includes a plurality of grooves. A first portion of the grooves are exposed grooves located at a surface of the chemical mechanical polishing pad. A second portion of the grooves are buried grooves embedded below the surface of the chemical mechanical polishing pad, such that, during use of the chemical mechanical polishing pad, one or more of the buried grooves are exposed at the surface.Type: GrantFiled: May 7, 2020Date of Patent: March 26, 2024Assignee: CMC MATERIALS LLCInventors: Paul Andre Lefevre, Devin Schmitt, Jaeseok Lee, Eric S. Moyer, Holland Hodges
-
Patent number: 11897486Abstract: Techniques described are related to determining when a discrepancy between data of multiple sensors (e.g., IMUs) might be attributable to a sensor error, as opposed to operating conditions, such as sensor bias or noise. For example, the sensor data is passed through one or more filters (e.g., bandpass filter) that model the bias or noise, and the filtered data may then be compared for consistency. In some examples, consistency may be based on residuals or some other metric describing discrepancy among the filtered sensor data.Type: GrantFiled: November 29, 2021Date of Patent: February 13, 2024Assignee: ZOOX, INC.Inventors: Derek Adams, Eric Andre Senant, Weihung Ko, Michael Carsten Bosse
-
Patent number: 11802131Abstract: The present invention provides selected glutarimides which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: GrantFiled: March 4, 2020Date of Patent: October 31, 2023Assignee: C4 Therapeutics, Inc.Inventors: Roger Norcross, Annick Goergler, Philipp Schmid, Fabian Dey, Eric Andre Kusznir
-
Patent number: 11787802Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: GrantFiled: January 14, 2022Date of Patent: October 17, 2023Assignee: C4 Therapeutics, Inc.Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
-
Patent number: 11757686Abstract: In an embodiment a device includes a first circuit and a second circuit, wherein the first circuit is configured to generate a fourth signal and a fifth signal by applying the phase shift respectively to a first signal and to a second signal and deliver a sixth signal corresponding to a sampling over one bit of the fourth signal, a seventh signal corresponding to a sampling over one bit of the fifth signal, an eighth signal corresponding to a sampling over one bit of a difference between the fourth and fifth signals, and a ninth signal corresponding to a sampling over one bit of a sum between the fourth and fifth signals, wherein the second circuit is configured to receive the sixth, seventh, eighth, and ninth signals and determine, during a first phase where the first and second signals are representative of a first known symbol of a QPSK constellation, a state of a first bit from among a first state and a second state based on the eighth and ninth signals.Type: GrantFiled: July 29, 2022Date of Patent: September 12, 2023Assignee: STMicroelectronics SAInventors: Eric Andre, Lionel Vogt
-
Publication number: 20230192643Abstract: The present invention provides dihydroquinolinone compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: ApplicationFiled: August 1, 2022Publication date: June 22, 2023Applicant: C4 Therapeutics, Inc.Inventors: Roger Norcross, Adrian Britschgi, Fabian Dey, Annick Goergler, Eric Andre Kusznir, Moreno Attilio Wichert
-
Publication number: 20230082027Abstract: A radar system is provided based on a core module comprising a radar transducer based on a long, flat platform, provided with coupling elements at each end, which may comprise ISO standard compatible corner fittings as used in freight containers Accessory modules may be connected to the core module by means of these coupling elements at each end. Accessory modules may provide power, communications, cooling or other support functions as required. The coupling achieved between the core module and accessory modules may be reinforced with side brackets, and may be sufficiently strong that the weight of the complete assembly may be supported by the core module, or by the accessory modules. The combined length of the core module and accessory modules may be elected to correspond essentially to the length of a standard freight container, and the length of the core module alone may be selected to correspond to the flat bed of a standard medium truck.Type: ApplicationFiled: February 10, 2020Publication date: March 16, 2023Inventors: Edwin Leonardus Josephus HOGEMAN, Eric André KAPPEL
-
Publication number: 20230034119Abstract: In an embodiment a device includes a first circuit and a second circuit, wherein the first circuit is configured to generate a fourth signal and a fifth signal by applying the phase shift respectively to a first signal and to a second signal and deliver a sixth signal corresponding to a sampling over one bit of the fourth signal, a seventh signal corresponding to a sampling over one bit of the fifth signal, an eighth signal corresponding to a sampling over one bit of a difference between the fourth and fifth signals, and a ninth signal corresponding to a sampling over one bit of a sum between the fourth and fifth signals, wherein the second circuit is configured to receive the sixth, seventh, eighth, and ninth signals and determine, during a first phase where the first and second signals are representative of a first known symbol of a QPSK constellation, a state of a first bit from among a first state and a second state based on the eighth and ninth signals.Type: ApplicationFiled: July 29, 2022Publication date: February 2, 2023Inventors: Eric Andre, Lionel Vogt
-
Patent number: 11526444Abstract: A method for facilitating predictive caching of data is provided. The method includes retrieving raw data relating to user activity for a plurality of users, the user activity including a history of web resources accessed by a user; converting the raw data into a structured data set based on a predetermined criterion; generating a model based on the structured data set; training the model by using a training data set, the training data set including the user activity for a predetermined period of time; determining, by using the trained model, a predicted first web resource for the user; and automatically caching, in a memory, the predicted first web resource.Type: GrantFiled: August 26, 2021Date of Patent: December 13, 2022Assignee: JPMorgan Chase Bank, N.A.Inventors: Ramin Koch, Eric-Andre Vigroux, Liang Zhou, Mathieu Cliche, Yihui Tang, Howard Spector, Rebecca Setting, Neil V O'Donnell, Timothy Lorenz
-
Publication number: 20220289738Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: ApplicationFiled: January 14, 2022Publication date: September 15, 2022Applicant: C4 Therapeutics, Inc.Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
-
Patent number: 11445457Abstract: A wireless communication system is provided including a first media device, a second media device, and a third media device, each media device configured to output media content. The first media device is designated as an access point media device that is configured to transmit media content to the second media device and the third media device. The first media device is configured to transmit the media content to the second media device using simplex communication instead of duplex communication based on a first confidence level indicator received from the second media device indicating a high level of confidence. The first media device is configured to transmit the media content to the third media device using duplex communication based on a second confidence level indicator received from the third media device a high level of confidence, and each media device is configured to output the media content in a synchronized manner.Type: GrantFiled: September 21, 2020Date of Patent: September 13, 2022Assignee: Logitech Europe S.A.Inventors: Eric Andre Tissot-Dupont, Vasanth Prabhakar Murari, Edison Liwanag David
-
Patent number: 11418559Abstract: A wireless communication system is provided including a group of media devices that includes a first media device, a second media device, a third media device, and a fourth media device. The first media device, during a first time period, is designated as an access point media device that is configured to transmit media content to each of the other media devices in the group. The second media device is configured to become the access point media device during a second time period and transmit media content to each of the other media devices in the group based on a determination that the second media device is better suited than the first media device to be the access point media device for the group during the second time period. Each media device is configured to output the media content transmitted by the access point media device in a synchronized manner.Type: GrantFiled: September 21, 2020Date of Patent: August 16, 2022Assignee: LOGITECH EUROPE S.A.Inventors: Eric Andre Tissot-Dupont, Vasanth Prabhakar Murari, Edison Liwanag David
-
Patent number: 11401256Abstract: The present invention provides dihydroquinolinone compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: GrantFiled: March 4, 2020Date of Patent: August 2, 2022Assignee: C4 Therapeutics, Inc.Inventors: Roger Norcross, Adrian Britschgi, Fabian Dey, Annick Goergler, Eric Andre Kusznir, Moreno Attilio Wichert
-
Publication number: 20220094726Abstract: A wireless communication system is provided including a group of media devices that includes a first media device, a second media device, a third media device, and a fourth media device. The first media device, during a first time period, is designated as an access point media device that is configured to transmit media content to each of the other media devices in the group. The second media device is configured to become the access point media device during a second time period and transmit media content to each of the other media devices in the group based on a determination that the second media device is better suited than the first media device to be the access point media device for the group during the second time period. Each media device is configured to output the media content transmitted by the access point media device in a synchronized manner.Type: ApplicationFiled: September 21, 2020Publication date: March 24, 2022Inventors: Eric Andre TISSOT-DUPONT, Vasanth Prabhakar MURARI, Edison Liwanag DAVID
-
Publication number: 20220095249Abstract: A wireless communication system is provided including a first media device, a second media device, and a third media device, each media device configured to output media content. The first media device is designated as an access point media device that is configured to transmit media content to the second media device and the third media device. The first media device is configured to transmit the media content to the second media device using simplex communication instead of duplex communication based on a first confidence level indicator received from the second media device indicating a high level of confidence. The first media device is configured to transmit the media content to the third media device using duplex communication based on a second confidence level indicator received from the third media device a high level of confidence, and each media device is configured to output the media content in a synchronized manner.Type: ApplicationFiled: September 21, 2020Publication date: March 24, 2022Inventors: Eric Andre TISSOT-DUPONT, Vasanth Prabhakar MURARI, Edison Liwanag DAVID
-
Publication number: 20220066932Abstract: A method for facilitating predictive caching of data is provided. The method includes retrieving raw data relating to user activity for a plurality of users, the user activity including a history of web resources accessed by a user; converting the raw data into a structured data set based on a predetermined criterion; generating a model based on the structured data set; training the model by using a training data set, the training data set including the user activity for a predetermined period of time; determining, by using the trained model, a predicted first web resource for the user; and automatically caching, in a memory, the predicted first web resource.Type: ApplicationFiled: August 26, 2021Publication date: March 3, 2022Applicant: JPMorgan Chase Bank, N.A.Inventors: Ramin KOCH, Eric-Andre VIGROUX, Liang ZHOU, Mathieu CLICHE, Yihui TANG, Howard SPECTOR, Rebecca SETTING, Neil V O'DONNELL, Su AMARATUNGA, Andy HOUSTON, Timothy LORENZ
-
Patent number: 11254672Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: GrantFiled: March 4, 2020Date of Patent: February 22, 2022Assignee: C4 Therapeutics, Inc.Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
-
Publication number: 20200207783Abstract: The present invention provides selected glutarimides which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.Type: ApplicationFiled: March 4, 2020Publication date: July 2, 2020Applicant: C4 Therapeutics, Inc.Inventors: Roger Norcross, Annick Goergler, Philipp Schmid, Fabian Dey, Eric Andre Kusznir